300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Construction
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Theatre
Climate
LGBT
Social
Cannabis
Celebrity
Life Science
Infrastructure
Food and Beverage
Publishing
Mobile Apps
Beauty
Wine and Spirits
Music
Fashion
Art
Manufacturing
Real Estate
Sporting Goods
Social Media
Financial Services
FinTech
Franchise
Non Profit
Finance
Internet
Digital Media
Mobile Advertising
Android
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
Ireland
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
El Salvador
Sierra Leone
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Algeria
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
UNIMED HEALTHCARE, VC Fund

UNIMED HEALTHCARE

VC Fund

Taipei, Taiwan

UNIMED HEALTHCARE is a VC fund in Taipei focused on Medical and Health Care. Unimed Healthcare represents and distributes products in the research field of life science.

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Industries UNIMED HEALTHCARE invests in

MedicalHealth CareBiotechnologyArtificial Intelligence

Stages UNIMED HEALTHCARE invests in

Pre-Seed

Countries UNIMED HEALTHCARE invests in

Taiwan

Investment Focus

Industry

  • Medical 1 (100%)
  • Health Care 1 (100%)
  • Biotechnology 1 (100%)
  • Artificial Intelligence 1 (100%)

Investments

CompanyDescriptionRoundLinks
CancerFree Biotech's platform E.V.A. (Ex Vivo Avatar) uses a proprietary culture system and AI image recognition to expand circulating tumor cells from just 20 mL of blood into 3D tumor organoids. These organoids drive personalized treatment by facilitating drug sensitivity testing and identifying the most effective drugs for each patient. Bytesting therapies directly on patient-derived cells and conducting proprietary organoid analysis, E.V.A. generates personalized screening reports tailored to each patient's unique tumor profile. E.V.A. also supports pharmaceutical companies by validating drug efficacy on patient-derived cells and identifying the most promising candidates for clinical trials. The organoid screening data offers early insights into drug efficacy, reducing the risk of late-stage trial failure and helping to select the best-in-class therapies. Additionally, as a more physiologically relevant model, E.V.A. eliminates the need for traditional cell line and animal testing, producing more accurate and clinically predictive data. $553.6K / Pre-Seed / Dec 01, 2018

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Construction
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Theatre
Climate
LGBT
Social
Cannabis
Celebrity
Life Science
Infrastructure
Food and Beverage
Publishing
Mobile Apps
Beauty
Wine and Spirits
Music
Fashion
Art
Manufacturing
Real Estate
Sporting Goods
Social Media
Financial Services
FinTech
Franchise
Non Profit
Finance
Internet
Digital Media
Mobile Advertising
Android
Proptech
Impact
Sustainability
Enterprise
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
Ireland
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
El Salvador
Sierra Leone
Tanzania
Senegal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Bangladesh
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Algeria
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does UNIMED HEALTHCARE invest in?

UNIMED HEALTHCARE invests primarily in Medical, Health Care and Biotechnology startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did UNIMED HEALTHCARE last invest?

The most recent investment recorded for UNIMED HEALTHCARE closed in Dec 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
UNIMED HEALTHCARE UNIMED HEALTHCARE Find emails